Page last updated: 2024-11-03

probenecid and Leukemia L 1210

probenecid has been researched along with Leukemia L 1210 in 12 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Research Excerpts

ExcerptRelevanceReference
" Since IAHQ has only modest activity against L1210 leukemia in mice, it was tested in combination with methotrexate (MTX), probenecid, or verapamil in an effort to enhance efficacy."1.27Effects of 5,8-dideazaisopteroylglutamate (IAHQ) on L1210 leukemia in mice when given alone and in combination with methotrexate, probenecid, or verapamil. ( Gale, GR; Hynes, JB; Smith, AB, 1986)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19906 (50.00)18.7374
1990's6 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gangji, D1
Ross, WE1
Bleyer, WA1
Poplack, DG1
Glaubiger, DL1
Sirotnak, FM3
Moccio, DM2
Hancock, CH1
Young, CW2
Sierra, EE2
Brigle, KE2
Spinella, MJ2
Goldman, ID2
Henderson, GB5
Hughes, TR1
O'Leary, DF1
Tsuji, JM2
Hynes, JB1
Smith, AB1
Gale, GR1
Kumar, HP1
Zevely, EM1

Other Studies

12 other studies available for probenecid and Leukemia L 1210

ArticleYear
Probenecid inhibition of methotrexate cytotoxicity in mouse L1210 leukemia cells.
    Cancer treatment reports, 1984, Volume: 68, Issue:3

    Topics: Animals; Cell Survival; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Drug Interacti

1984
Improved methotrexate therapy of murine tumors obtained by probenecid-mediated pharmacological modulation at the level of membrane transport.
    Cancer research, 1981, Volume: 41, Issue:10

    Topics: Animals; Biological Transport, Active; Bone Marrow; Female; Kidney; Kinetics; Leukemia L1210; Liver;

1981
Increased accumulation of methotrexate by murine tumor cells in vitro in the presence of probenecid which is mediated by a preferential inhibition of efflux.
    Cancer research, 1981, Volume: 41, Issue:3

    Topics: Animals; Biological Transport; Carcinoma, Ehrlich Tumor; Leukemia L1210; Methotrexate; Mice; Neoplas

1981
Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.
    Biochemical pharmacology, 1995, Oct-12, Volume: 50, Issue:8

    Topics: Animals; Biological Transport; Carrier Proteins; Folate Receptors, GPI-Anchored; Hydrogen-Ion Concen

1995
Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
    The Journal of biological chemistry, 1995, Apr-07, Volume: 270, Issue:14

    Topics: Alkenes; Animals; Biological Transport; Carrier Proteins; Energy Metabolism; Folate Receptors, GPI-A

1995
Altered expression of unidirectional extrusion routes for methotrexate and cholate in an efflux variant of L1210 cells.
    Biochimica et biophysica acta, 1993, Oct-10, Volume: 1152, Issue:1

    Topics: Animals; Cell Division; Cholic Acids; Drug Interactions; Drug Tolerance; Exocytosis; Leukemia L1210;

1993
Separation and inhibitor specificity of a second unidirectional efflux route for methotrexate in L1210 cells.
    Biochimica et biophysica acta, 1992, Oct-05, Volume: 1110, Issue:2

    Topics: Adenosine Triphosphate; Animals; Biological Transport; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Le

1992
The issues of transport multiplicity and energetics pertaining to methotrexate efflux in L1210 cells addressed by an analysis of cis and trans effects of inhibitors.
    Cancer research, 1991, Mar-01, Volume: 51, Issue:5

    Topics: Adenosine Triphosphate; Animals; Biological Transport; Energy Metabolism; Leukemia L1210; Methotrexa

1991
Identification of cholate as a shared substrate for the unidirectional efflux systems for methotrexate in L1210 mouse cells.
    Biochimica et biophysica acta, 1990, Jan-23, Volume: 1051, Issue:1

    Topics: Animals; Biological Transport; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cholic Acids; Cytochalasin

1990
Effects of 5,8-dideazaisopteroylglutamate (IAHQ) on L1210 leukemia in mice when given alone and in combination with methotrexate, probenecid, or verapamil.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Folic Acid Antagonists; Leukemia L1210; Mal

1986
Characterization of the individual transport routes that mediate the influx and efflux of methotrexate in CCRF-CEM human lymphoblastic cells.
    Cancer research, 1986, Volume: 46, Issue:4 Pt 1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters;

1986
Inhibitory effects of probenecid on the individual transport routes which mediate the influx and efflux of methotrexate in L1210 cells.
    Biochemical pharmacology, 1985, May-15, Volume: 34, Issue:10

    Topics: Animals; Biological Transport; Cells, Cultured; Energy Metabolism; Leukemia L1210; Methotrexate; Mic

1985